Adapting the Translational Science Benefits Model to improve health and advance health equity in diabetes: The Centers for Diabetes Translation Research Impact Framework.

Julie A Schmittdiel, William H Herman, Pamela Thornton, Marlon Pragnell, Debra Haire-Joshu
Author Information
  1. Julie A Schmittdiel: Kaiser Permanente Northern California Division of Research, Pleasanton, CA, USA. ORCID
  2. William H Herman: University of Michigan Schools of Medicine and Public Health, Ann Arbor, MI, USA.
  3. Pamela Thornton: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
  4. Marlon Pragnell: American Diabetes Association, Arlington, VA, USA.
  5. Debra Haire-Joshu: Washington University Brown School and School of Medicine, St. Louis, MO, USA.

Abstract

No abstract text available.

References

  1. Prev Chronic Dis. 2018 Jan 04;15:E02 [PMID: 29300695]
  2. Diabetes Care. 2022 May 1;45(5):e97-e98 [PMID: 35561138]
  3. Transl Vis Sci Technol. 2020 Jul 14;9(8):22 [PMID: 32855869]
  4. Am J Prev Med. 2018 Mar;54(3):341-351 [PMID: 29455756]
  5. Obesity (Silver Spring). 2019 Apr;27(4):535-541 [PMID: 30900408]
  6. J Clin Transl Sci. 2017 Feb;1(1):60-66 [PMID: 28480056]
  7. Clin Transl Sci. 2018 Jan;11(1):77-84 [PMID: 28887873]
  8. J Gen Intern Med. 2018 Jan;33(1):9-10 [PMID: 28971299]

Grants

  1. P30 DK092950/NIDDK NIH HHS